EZH2 overexpression resulted in an increase of bioluminescence from tumours, tumour volume and tumour weight compared with the vector control group, suggesting that EZH2 overexpression promoted OSCC growth in vivo (Figure 6A, 6B and 6C). This evidence concerns the gene EZH2 and neoplasm.